Brought to you by 
Pozen closes $78.7mm IPO
14 Nov 2000
Executive Summary
Pozen Inc. (migraine treatment) completed its initial public offering of 5.75mm common shares (including the overallotment) at $15 apiece, netting $78.7mm.
Deal Industry
- Biotechnology
- Pharmaceuticals
Deal Status
- Final
Deal Type
-
Financing
- IPO
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com